Nurix Therapeutics, Inc. (NRIX) insider activity

Nurix Therapeutics, Inc. (NRIX): 0 insider buys and 4 sales reported in the last 90 days.

The CFO sold $74,475 of Nurix Therapeutics, Inc. stock. People sell for many reasons (taxes, a house, diversifying), so a sale means far less than a purchase. (2026-11-03)
A top executive sold $103,986 of Nurix Therapeutics, Inc. stock. People sell for many reasons (taxes, a house, diversifying), so a sale means far less than a purchase. (2026-11-03)
A top executive sold $38,914 of Nurix Therapeutics, Inc. stock. People sell for many reasons (taxes, a house, diversifying), so a sale means far less than a purchase. (2026-11-03)
A top executive sold $103,986 of Nurix Therapeutics, Inc. stock. People sell for many reasons (taxes, a house, diversifying), so a sale means far less than a purchase. (2026-11-03)

Reported	Who	Stock	What	Amount	Source
2026-11-03	van Houte Hans Chief Financial Officer	NRIX Nurix Therapeutics, Inc.	Sold	$74,475	SEC filing
2026-11-03	Ring Christine Chief Legal Officer	NRIX Nurix Therapeutics, Inc.	Sold	$103,986	SEC filing
2026-11-03	Hansen Gwenn Chief Scientific Officer	NRIX Nurix Therapeutics, Inc.	Sold	$38,914	SEC filing
2026-11-03	Hansen Gwenn Chief Scientific Officer	NRIX Nurix Therapeutics, Inc.	Sold	$103,986	SEC filing

All insider buys · Legends

TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.